Brennan-Laun Sarah E, Ezelle Heather J, Li Xiao-Ling, Hassel Bret A
1 Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine , Baltimore, Maryland.
J Interferon Cytokine Res. 2014 Apr;34(4):275-88. doi: 10.1089/jir.2013.0147.
RNase-L is a mediator of type 1 interferon-induced antiviral activity that has diverse and critical cellular roles, including the regulation of cell proliferation, differentiation, senescence and apoptosis, tumorigenesis, and the control of the innate immune response. Although RNase-L was originally shown to mediate the endonucleolytic cleavage of both viral and ribosomal RNAs in response to infection, more recent evidence indicates that RNase-L also functions in the regulation of cellular mRNAs as an important mechanism by which it exerts its diverse biological functions. Despite this growing body of work, many questions remain regarding the roles of mRNAs as RNase-L substrates. This review will survey known and putative mRNA substrates of RNase-L, propose mechanisms by which it may selectively cleave these transcripts, and postulate future clinical applications.
核糖核酸酶L(RNase-L)是1型干扰素诱导的抗病毒活性的介质,具有多种关键的细胞作用,包括调节细胞增殖、分化、衰老和凋亡、肿瘤发生以及控制先天免疫反应。尽管最初表明RNase-L可介导病毒和核糖体RNA在感染时的内切核酸酶切割,但最近的证据表明,RNase-L还作为调节细胞mRNA的一种重要机制发挥作用,通过该机制它发挥其多种生物学功能。尽管这项工作越来越多,但关于mRNA作为RNase-L底物的作用仍有许多问题。本综述将概述RNase-L已知和推测的mRNA底物,提出其可能选择性切割这些转录本的机制,并推测未来的临床应用。